MCM
HALO icon

Moore Capital Management’s Halozyme HALO Stock Holding History

Moore Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-100,000
Closed -$1.28M – 239
2017
Q2 		$1.28M Buy
100,000
+50,000
+100% +$668K 0.04% 149
2017
Q1 		$648K Hold
50,000
– – 0.02% 177
2016
Q4 		$494K Buy
50,000
+12,500
+33% +$137K 0.02% 157
2016
Q3 		$453K Buy
+37,500
New +$383K 0.02% 196

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Moore Capital Management's HALO Position: Q3 2017 in Review

Moore Capital Management sold out of Halozyme (HALO) in Q3 2017, closing a stake of 100,000 shares — an estimated $1.28M sold.

Moore Capital Management first reported a position in HALO in Q3 2016 and held it in 4 quarters. The position peaked at $1.28M in Q2 2017. 166 funds tracked by Wall St. Rank hold HALO as of Q3 2017.

  • Moore Capital Management reported no remaining Halozyme position as of Q3 2017 after selling out during the quarter.
  • Moore Capital Management sold 100,000 Halozyme shares in Q3 2017, an estimated $1.28M.
  • Moore Capital Management first reported a position in Halozyme in Q3 2016 and held it in 4 quarters.
  • Moore Capital Management's Halozyme position peaked at $1.28M in Q2 2017.
  • 166 funds tracked by Wall St. Rank held Halozyme as of Q3 2017.

Based on Moore Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.